Tag | Content |
---|
EnhancerAtlas ID | HS109-13288 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr2:219197030-219198480 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr2:219197258-219197276 | CCTTCCCTTCCTCCTTCC | - | 6.75 | STAT1 | MA0137.3 | chr2:219197082-219197093 | TTTCCCAGAAA | - | 6.02 | STAT3 | MA0144.2 | chr2:219197082-219197093 | TTTCCCAGAAA | - | 6.32 | ZNF263 | MA0528.1 | chr2:219197257-219197278 | CCCTTCCCTTCCTCCTTCCCC | - | 6.69 | ZNF263 | MA0528.1 | chr2:219197254-219197275 | CTCCCCTTCCCTTCCTCCTTC | - | 8.7 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_12853 | chr2:219197145-219197428 | CD34_fetal | SE_12853 | chr2:219197907-219198081 | CD34_fetal | SE_13117 | chr2:219196452-219199553 | CD34_Primary_RO01480 | SE_13701 | chr2:219196195-219199714 | CD34_Primary_RO01536 | SE_14263 | chr2:219196134-219199851 | CD34_Primary_RO01549 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I218331 | chr2 | 219196125 | 219199490 |
|
Enhancer Sequence | TGGTTGCATA TGCCAGGGAG AGGGCTAAAT GCAACTGCGA GGACAGGGGG CCTTTCCCAG 60 AAAGAGAAGA AGCAGGATGG GGAGCTGACC ATGGGGACTG TCACTCACCA ATTCTGCAGG 120 CAGATGGAGG GAGAGCCTAA GCTAAGTGGC TTAGAGAGTC CTGTGGAAGC CCTTGGCAGG 180 GCAGGGCACA GGGCTGGGGA GAGCCACTAG GTCCTCAGGC TGCTCTCCCC TTCCCTTCCT 240 CCTTCCCCAT CTCAGCCCTG CCTTCTCCTG CTTTGCCCAA AGATCAAGAC CTCAGGCCAG 300 CAAGGACTGC AACCTGTCCC TAGCCCACAT CCAAGCCAGG CACAGGTCTC CCATCCCCCT 360 GCCACCCCAC CCTCTCCACC TTCAGCACCC CCTCTATCCA GGCCCCTGTC TCTCTCCCAC 420 CTGGATGACT CGGTACCTCC TGCCCCTTTT CTCCACTCAG CAGCCCAGTG AGCTCTCAGA 480 AAGGGAGTCT GATCCTGTGC ACCCTGTTCT AACAACCACC AGCCATTTTC CACTCTCTGC 540 ATGGCCTGGC CCCTGCCCAC CTCACCAACC CCTTCTCCAG CACTGTTGGT CCCTCCAGCC 600 CTGCCCAAAG ACTCCGAGGC CTCCTGACAA TTCCTAAAAT TCCACACTCC TCCTGCCTTG 660 GTGCCACATC ACCCAGAACC GTCCATGCCG CTGGCTCGGT CTTGCAGTTT CCAGCACGAA 720 TGTCACCCTC TGGGGACGAG GCCTTCCCTG GGCACCCTGT CTACAGTAGG GCCTCTTCCC 780 TTCCGGCCAC TCTTTTCCAC CCCCAGCCAT AGTTACTGGC AGTTTGCTGA CTAATCCGGT 840 TTCTGGTTTA ATGTCTGTTG GCCCTCCCTT TCCCCACATT ACAAGCTCCC CGAAAGCAGG 900 ACCCCTTCTG CCTTGTTTCT GCTGTCTCCA CTGTGTCCAT CATGCACAGT ATTTGCCAGA 960 TACAGCGAGT GACAAGGAGG GGCCTTGTTT ACTGCGGCTT CTTGGTGCAG AGTCCCTGCC 1020 CGCACAGATC TGTCCTTTCT TAGGGACAGA ACCTGGGAAC ACGTAGTCAG CATTTAGTAA 1080 GGGGAGGCGG GGAGCTTATC ACCCCTCCCA GATGTGCATG ACCCTGCTCT AGCAGCTGGG 1140 AGGACTTCCT GGCTGAATTT GGGAAGGAAA CAACAGTTGC TAAACATCTT CCACTTGCCA 1200 GGCTCTCGGC TGAGTGCTTT ACATTAGTTT TCTTATTTTA GGCACTTAAT CTTCACACAG 1260 TCCTTCGGGG TAAGTCACAG CATTGCCATG TTATAGATGA GGAACCTCAT CTGTGAAACT 1320 CATGACTTGC CCAAGGTCAC AGAGTCAACA GGGGCCAGGC TATGATGGGA GCCCAGATCT 1380 TTCTGTTGCC AGAGCCTCTG TTCTTTCCAT AAGCCCATGT AGCGAGAAAT GAAGACAGGA 1440 ATGGGACTCA 1450
|